% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Llorens:151070,
author = {Llorens, Franc and Villar-Piqué, Anna and Hermann, Peter
and Schmitz, Matthias and Calero, Olga and Stehmann,
Christiane and Sarros, Shannon and Moda, Fabio and Ferrer,
Isidre and Poleggi, Anna and Pocchiari, Maurizio and
Catania, Marcella and Klotz, Sigrid and O’Regan, Carl and
Brett, Francesca and Heffernan, Josephine and Ladogana, Anna
and Collins, Steven J. and Calero, Miguel and Kovacs, Gabor
G. and Zerr, Inga},
title = {{D}iagnostic {A}ccuracy of {P}rion {D}isease {B}iomarkers
in {I}atrogenic {C}reutzfeldt-{J}akob {D}isease},
journal = {Biomolecules},
volume = {10},
number = {2},
issn = {2218-273X},
address = {Basel},
publisher = {MDPI},
reportid = {DZNE-2020-01055},
pages = {290},
year = {2020},
note = {https://www.mdpi.com/2218-273X/10/2/290},
abstract = {Human prion diseases are classified into sporadic, genetic,
and acquired forms. Within this last group, iatrogenic
Creutzfeldt–Jakob disease (iCJD) is caused by
human-to-human transmission through surgical and medical
procedures. After reaching an incidence peak in the 1990s,
it is believed that the iCJD historical period is probably
coming to an end, thanks to lessons learnt from past
infection sources that promoted new prion prevention and
decontamination protocols. At this point, we sought to
characterise the biomarker profile of iCJD and compare it to
that of sporadic CJD (sCJD) for determining the value of
available diagnostic tools in promptly recognising iCJD
cases. To that end, we collected 23 iCJD samples from seven
national CJD surveillance centres and analysed the
electroencephalogram and neuroimaging data together with a
panel of seven CSF biomarkers: 14-3-3, total tau,
phosphorylated/total tau ratio, alpha-synuclein,
neurofilament light, YKL-40, and real-time quaking induced
conversion of prion protein. Using the cut-off values
established for sCJD, we found the sensitivities of these
biomarkers for iCJD to be similar to those described for
sCJD. Given the limited relevant information on this issue
to date, the present study validates the use of current sCJD
biomarkers for the diagnosis of future iCJD cases.},
keywords = {Adult / Aged / Biomarkers: cerebrospinal fluid / Corneal
Transplantation: adverse effects / Creutzfeldt-Jakob
Syndrome: cerebrospinal fluid / Creutzfeldt-Jakob Syndrome:
diagnostic imaging / Creutzfeldt-Jakob Syndrome:
epidemiology / Dura Mater: transplantation /
Electroencephalography / Encephalopathy, Bovine Spongiform:
cerebrospinal fluid / Encephalopathy, Bovine Spongiform:
diagnostic imaging / Encephalopathy, Bovine Spongiform:
epidemiology / Female / Homozygote / Human Growth Hormone:
adverse effects / Humans / Iatrogenic Disease / Kaplan-Meier
Estimate / Magnetic Resonance Imaging / Male / Methionine:
genetics / Middle Aged / Neuroimaging / Phenotype /
Polymorphism, Genetic / Prion Diseases: cerebrospinal fluid
/ Prion Diseases: diagnostic imaging / Prion Proteins:
metabolism / Registries / Reproducibility of Results / Sex
Factors / Time Factors},
cin = {AG Zerr},
ddc = {570},
cid = {I:(DE-2719)1440011-1},
pnm = {344 - Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-344},
typ = {PUB:(DE-HGF)16},
pmc = {pmc:PMC7072321},
pubmed = {pmid:32059611},
doi = {10.3390/biom10020290},
url = {https://pub.dzne.de/record/151070},
}